» Articles » PMID: 27598380

Drug-drug Interactions and Adverse Drug Reactions in Polypharmacy Among Older Adults: an Integrative Review

Overview
Specialty Nursing
Date 2016 Sep 7
PMID 27598380
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: to identify and summarize studies examining both drug-drug interactions (DDI) and adverse drug reactions (ADR) in older adults polymedicated.

Methods: an integrative review of studies published from January 2008 to December 2013, according to inclusion and exclusion criteria, in MEDLINE and EMBASE electronic databases were performed.

Results: forty-seven full-text studies including 14,624,492 older adults (≥ 60 years) were analyzed: 24 (51.1%) concerning ADR, 14 (29.8%) DDI, and 9 studies (19.1%) investigating both DDI and ADR. We found a variety of methodological designs. The reviewed studies reinforced that polypharmacy is a multifactorial process, and predictors and inappropriate prescribing are associated with negative health outcomes, as increasing the frequency and types of ADRs and DDIs involving different drug classes, moreover, some studies show the most successful interventions to optimize prescribing.

Conclusions: DDI and ADR among older adults continue to be a significant issue in the worldwide. The findings from the studies included in this integrative review, added to the previous reviews, can contribute to the improvement of advanced practices in geriatric nursing, to promote the safety of older patients in polypharmacy. However, more research is needed to elucidate gaps.

Objetivo: identificar y resumir los estudios que analizan tanto las interacciones medicamentosas (IM) como las reacciones adversas a medicamentos (RAM) en los adultos mayores polimedicados.

MÉtodos: revisión integradora de estudios publicados entre enero de 2008 a diciembre de 2013, siguiendo criterios de inclusión y exclusión, en las bases de datos electrónicas MEDLINE y EMBASE.

Resultados: cuarenta y siete estudios de texto completo incluidos fueron analizados incluyendo 14,624,492 adultos mayores (≥ 60 años), de ellos 24 (51,1%) en relación con RAM, 14 (29,9%) con IM y 9 estudios (19,1%) que investigaron tanto IM como RAM. Encontramos una gran variedad de diseños metodológicos. Los estudios revisados reforzaron el concepto que la polifarmacia es un proceso multifactorial, y los predictores y la prescripción inadecuada se asocian con resultados negativos para la salud tales como el aumento de la frecuencia y tipos de RAM y IM implicando diferentes clases de fármacos, además que algunos estudios muestran cuales son las intervenciones más exitosas para optimizar la prescripción.

ConclusÕes: IM e RAM entre idosos continuam a ser um problema significativo no mundo todo. Os resultados dos estudos incluídos nesta revisão integrativa, adicionado às revisões anteriores, podem contribuir para a melhoria das práticas avançadas de enfermagem geriátrica, para promover a segurança dos pacientes idosos em polifarmácia. No entanto, são necessárias mais pesquisas para elucidar lacunas.

Conclusiones: IM y RAM siguen siendo un problema importante en el mundo entero entre los adultos mayores. Los resultados de los estudios incluidos en esta revisión integradora, sumado a las revisiones previas, pueden contribuir a la mejora de las prácticas avanzadas de enfermería geriátrica, para promover la seguridad de los pacientes de mayor edad en la polifarmacia. Sin embargo, se necesita más investigación para esclarecer los vacíos de conocimiento.

Citing Articles

The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study.

Berthelot W, Sirois C, Julien A, Amiable N, Bessette L, Desaulniers P Rheumatol Int. 2025; 45(3):44.

PMID: 39921727 DOI: 10.1007/s00296-025-05804-8.


Adverse Drug Reactions Among Hospitalized Psychiatric Patients, Prevalence, Severity, Preventability, and Opportunities for Intervention.

Al Hindi A, Al Balushi S, Al Ruzaiqi S, Al Busafi S, Abdulmonem S, Ali I Oman Med J. 2024; 39(3):e631.

PMID: 39564097 PMC: 11574781. DOI: 10.5001/omj.2024.75.


.

Chadli Z, Kasraoui K, Hannachi I, Chaabane A, Klii R, Ben Romdhane H Tunis Med. 2024; 102(10):682-689.

PMID: 39441168 PMC: 11574366. DOI: 10.62438/tunismed.v102i10.4970.


A Phenomenological Approach to Medication Adherence in Elderly Patients: A Qualitative Study.

Liquori G, Panattoni N, De Leo A, Dionisi S, Giannetta N, Gasperi B Healthcare (Basel). 2024; 12(19).

PMID: 39408105 PMC: 11476112. DOI: 10.3390/healthcare12191925.


Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events.

Huo B, Shu L, Xiao J, Yin N, Ai M, Jia Y Front Pharmacol. 2024; 15:1292163.

PMID: 39403147 PMC: 11471622. DOI: 10.3389/fphar.2024.1292163.


References
1.
Gallagher P, OMahony D . STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008; 37(6):673-9. DOI: 10.1093/ageing/afn197. View

2.
Klopotowska J, Wierenga P, Smorenburg S, Stuijt C, Arisz L, Kuks P . Recognition of adverse drug events in older hospitalized medical patients. Eur J Clin Pharmacol. 2012; 69(1):75-85. PMC: 3536996. DOI: 10.1007/s00228-012-1316-4. View

3.
Somers A, Mallet L, Van Der Cammen T, Robays H, Petrovic M . Applicability of an adapted medication appropriateness index for detection of drug-related problems in geriatric inpatients. Am J Geriatr Pharmacother. 2012; 10(2):101-9. DOI: 10.1016/j.amjopharm.2012.01.003. View

4.
Rassen J, Choudhry N, Avorn J, Schneeweiss S . Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation. 2009; 120(23):2322-9. PMC: 2818789. DOI: 10.1161/CIRCULATIONAHA.109.873497. View

5.
Venturini C, Engroff P, Ely L, Zago L, Schroeter G, Gomes I . Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics (Sao Paulo). 2011; 66(11):1867-72. PMC: 3203957. DOI: 10.1590/s1807-59322011001100004. View